Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups

Sponsor
National Institute of Dental and Craniofacial Research (NIDCR) (NIH)
Overall Status
Completed
CT.gov ID
NCT00004781
Collaborator
Columbia University (Other)
250

Study Details

Study Description

Brief Summary

OBJECTIVES: I. Evaluate the development of oral manifestations of human immunodeficiency virus infection in relationship to the onset of immunologic alterations and systemic symptoms in different risk groups: gay/bisexual men, male intravenous drug users, and female intravenous drug users.

  1. Evaluate the immune and inflammatory response to periodontal and other microbial pathogens.

  2. Evaluate the bacterial species infecting the oral cavity in patients in these risk groups.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    PROTOCOL OUTLINE:

    Patients undergo a periodontal assessment every 6 months until medically unable to continue. The oral/dental exam includes saliva and gingival crevicular fluid analysis and, as indicated, oral photographs.

    Study Design

    Study Type:
    Observational
    Study Start Date :
    Sep 1, 1989

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      0 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      PROTOCOL ENTRY CRITERIA:

      --Disease Characteristics-- Human immunodeficiency virus infection (HIV) seropositive or seronegative At risk for HIV, i.e.: Gay/bisexual men Male intravenous drug users Female intravenous drug users No acquired immunodeficiency syndrome Currently enrolled in Columbia Presbyterian Medical Center protocol "The Natural History and Progression of HIV Infection"

      Contacts and Locations

      Locations

      No locations specified.

      Sponsors and Collaborators

      • National Institute of Dental and Craniofacial Research (NIDCR)
      • Columbia University

      Investigators

      • Study Chair: Ira B. Lamster, Columbia University

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00004781
      Other Study ID Numbers:
      • 199/11861
      • CU-SDOS-5059
      First Posted:
      Feb 25, 2000
      Last Update Posted:
      Jun 24, 2005
      Last Verified:
      Feb 1, 1997

      Study Results

      No Results Posted as of Jun 24, 2005